Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An Author's Perspective
    • Ask the Experts
    • Bioanalysis articles
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Spotlights
    • Tech Digest
    • T&F journals

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Awareness
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Professional development
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Gene therapy R&D roadmap – tools and techniques

18 Nov 2019
An Author's Perspective General interest

This In the Zone infographic explores the tools and techniques used during the AAV gene therapy development pathway, detailing the neccessary steps during the process; from rAAV generation and in vitro and in vivo testing through to assessing the host immune response.

 


 

itz-gene-therapy-banner

Top content

  • Highlights from the 20th WRIB
  • Sapient introduces tumor protein mapping platform
  • Application Note: Comparing ultrasensitive SMC® immunoassay platforms with SMC® kits

Related tags

Absorption Systems gene therapy in the zone techniques tools
Previous article Next article

Related articles

15 AUG 2023 INTERVIEWS
Immunogenicity considerations for AAV gene therapy: an interview with Bonnie Wu
23 OCT 2019 GENERAL INTEREST
In the Zone: immunogenicity
4 NOV 2021 INTERVIEWS
Automated immunoassays are fast tracking cell and gene therapy workflows
6 SEP 2019 GENERAL INTEREST
In the Zone: Peptide Bioanalysis Sample Preparation
18 NOV 2024 INTERVIEWS
The essential role of bioanalysis in AAV therapy success: an interview with Catherine Spickler and John Cook
13 JUL 2023 NEWS
FDA approved: the first hemophilia A gene therapy authorized for the United States
  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Permissions
  • Whitelist Emails
  • Zone Leaders

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone